Edwards Lifesciences Corp

Edwards Lifesciences develops and commercializes medical devices for the treatment of advanced cardiovascular diseases. The company's primary focus is transcatheter heart valve technologies, which enable minimally invasive replacement and repair of damaged heart valves. Its transcatheter aortic valve replacement products operate under the SAPIEN family of valve systems, while mitral and tricuspid valve repair and replacement solutions are marketed under the PASCAL and EVOQUE brands. The company also manufactures surgical heart valve products, including aortic valves sold under the INSPIRIS and INSPIRIS RESILIA brands, as well as tissue valve conduits for complex cardiac procedures.

Geographically, Edwards Lifesciences operates across the United States, Europe, Japan, and other international markets, distributing its products through a combination of direct sales personnel and independent distributors. The company employs approximately 16,000 full-time employees and maintains headquarters in Irvine, California. Edwards Lifesciences was founded in 1958 and is incorporated in Delaware.